K Symvoulakis E, Bouloukaki I, Christodoulakis A, Aravantinou-Karlatou A, Tsiligianni I
Curr Oncol. 2025; 32(1).
PMID: 39851924
PMC: 11764254.
DOI: 10.3390/curroncol32010008.
Satoh S, Shah M, Sungelo M, Falzon L, Makhnevich A, Bade B
J Gen Intern Med. 2024; .
PMID: 39538041
DOI: 10.1007/s11606-024-09097-8.
Marjanovic S, Page A, Stone E, Currie D, Rankin N, Myers R
Transl Lung Cancer Res. 2024; 13(10):2466-2478.
PMID: 39507020
PMC: 11535840.
DOI: 10.21037/tlcr-24-425.
Tan N, Lowenstein L, Douglas E, Silva J, Bershad J, An J
BMC Prim Care. 2024; 25(1):373.
PMID: 39425032
PMC: 11490179.
DOI: 10.1186/s12875-024-02610-2.
Reddy A, Abe-Nornes F, Haskell A, Saito M, Schumacher M, Venkat A
Cost Eff Resour Alloc. 2024; 22(1):63.
PMID: 39237997
PMC: 11378520.
DOI: 10.1186/s12962-024-00573-w.
Patient Perspectives on a Patient-Facing Tool for Lung Cancer Screening.
Tiase V, Richards G, Taft T, Stevens L, Balbin C, Kaphingst K
Health Expect. 2024; 27(4):e14143.
PMID: 38992907
PMC: 11239535.
DOI: 10.1111/hex.14143.
A new communication approach to encourage lung cancer screening action in rural eligible populations.
Boatman D, McCauley-Hixenbaugh L, Starkey A, Allen A, Kennedy-Rea S
PEC Innov. 2024; 4:100298.
PMID: 38962501
PMC: 11219952.
DOI: 10.1016/j.pecinn.2024.100298.
University of Pennsylvania Telehealth Research Center of Excellence.
Wainwright J, Aggarwal C, Beucker S, Dougherty D, Gabriel P, Jacobs L
J Natl Cancer Inst Monogr. 2024; 2024(64):62-69.
PMID: 38924794
PMC: 11207744.
DOI: 10.1093/jncimonographs/lgae011.
Patient Lung Cancer Screening Decisions and Environmental and Psychosocial Factors.
Richmond J, Fernandez J, Bonnet K, Sellers A, Schlundt D, Forde A
JAMA Netw Open. 2024; 7(5):e2412880.
PMID: 38819825
PMC: 11143466.
DOI: 10.1001/jamanetworkopen.2024.12880.
Facilitators and Barriers to Lung Cancer Screening during Long COVID: A Global Systematic Review and Meta-Study Synthesis of Qualitative Research.
Gebru Gebremeskel T, Romeo F, Shama A, Bonevski B, Trigg J
Int J Environ Res Public Health. 2024; 21(5).
PMID: 38791759
PMC: 11121223.
DOI: 10.3390/ijerph21050534.
The TELEhealth Shared decision-making Coaching and Navigation in Primary carE (TELESCOPE) intervention: a study protocol for delivering shared decision-making for lung cancer screening by patient navigators.
Tan N, Lowenstein L, Douglas E, Silva J, Bershad J, An J
Res Sq. 2024; .
PMID: 38746205
PMC: 11092847.
DOI: 10.21203/rs.3.rs-4254047/v1.
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
Potter A, Xu N, Senthil P, Srinivasan D, Lee H, Gazelle G
J Clin Oncol. 2024; 42(17):2026-2037.
PMID: 38537159
PMC: 11191064.
DOI: 10.1200/JCO.23.01780.
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders.
Dodd R, Sharman A, Yap M, Stone E, Marshall H, Rhee J
Transl Lung Cancer Res. 2024; 13(2):240-255.
PMID: 38496699
PMC: 10938089.
DOI: 10.21037/tlcr-23-623.
Implementation considerations for risk-tailored cancer screening in the population: A scoping review.
Dunlop K, Singh N, Robbins H, Zahed H, Johansson M, Rankin N
Prev Med. 2024; 181:107897.
PMID: 38378124
PMC: 11106520.
DOI: 10.1016/j.ypmed.2024.107897.
Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco.
Bilenduke E, Anderson S, Brenner A, Currier J, Eberth J, King J
Cancer Causes Control. 2023; 34(Suppl 1):209-216.
PMID: 37713024
PMC: 10689540.
DOI: 10.1007/s10552-023-01790-z.
Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
Li J, Stults C, Liang S, Martinez M
BMC Cancer. 2023; 23(1):809.
PMID: 37644406
PMC: 10463613.
DOI: 10.1186/s12885-023-11256-9.
Variation in Reporting of Incidental Findings on Initial Lung Cancer Screening and Associations With Clinician Assessment.
Melzer A, Atoma B, Fabbrini A, Campbell M, Clothier B, Fu S
J Am Coll Radiol. 2023; 21(1):118-127.
PMID: 37516160
PMC: 11155613.
DOI: 10.1016/j.jacr.2023.03.023.
The global burden of lung cancer: current status and future trends.
Leiter A, Veluswamy R, Wisnivesky J
Nat Rev Clin Oncol. 2023; 20(9):624-639.
PMID: 37479810
DOI: 10.1038/s41571-023-00798-3.
Factors associated with lung cancer risk factor documentation.
Marcotte L, Khor S, Flum D, Akinsoto N, Chaudhari V, Wood D
Am J Manag Care. 2023; 29(9):439-447.
PMID: 37428463
PMC: 10761004.
DOI: 10.37765/ajmc.2023.89354.
Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.
Vachani A, Caruso C
Curr Opin Pulm Med. 2023; 29(4):232-238.
PMID: 37191171
PMC: 10247528.
DOI: 10.1097/MCP.0000000000000974.